Post - COVID – 19 ophthalmic syndromes, Neuro-ophthalmic Manifestations

Main Article Content

Abdullaev Shakhzodbek
Mamatkhujaeva Gulnara,
Abdullaev Aybek

Abstract

Coronavirus disease (COVID – 19) was one of the most severe pandemics that the world has ever experienced. The infection can range from asymptomatic, mild to life threatening respiratory distress. It can affect almost every organ of the body including the organ of vision. This review was carried out to facilitate the diagnostics and initiation of comprehensive therapy of neuro-ophthalmic manifestations that occur as a complication of coronavirus disease. Ophthalmic manifestations may be present in the clinical manifestation of COVID-19 infection or they may develop later in rehabilitation period or following the recovery. Ophthalmologists should be aware of the possible associations of ocular diseases with SARS-CoV-2 in order to look for specific signs, advise appropriate tests, diagnose and initiate early treatment for life and vision threatening complications.

Article Details

How to Cite
Abdullaev Shakhzodbek, Mamatkhujaeva Gulnara, & Abdullaev Aybek. (2022). Post - COVID – 19 ophthalmic syndromes, Neuro-ophthalmic Manifestations. The Peerian Journal, 8, 21–28. Retrieved from https://peerianjournal.com/index.php/tpj/article/view/279
Section
Articles

References

Invernizzi A, Pellegrini M, Messenio D, Cereda M, Olivieri P, Brambilla AM, et al Impending central retinal vein occlusion in a patient with coronavirus disease 2019 (COVID-19) Ocul Immunol Inflamm. 2020;28:1290–2

Walinjkar JA, Makhija SC, Sharma HR, Morekar SR, Natarajan S. Central retinal vein occlusion with COVID-19 infection as the presumptive etiology Indian J Ophthalmol. 2020;68:2572–4

Sheth JU, Narayanan R, Goyal J, Goyal V. Retinal vein occlusion in COVID-19: A novel entity Indian J Ophthalmol. 2020;68:2291–3

Gaba WH, Ahmed D, Al Nuaimi RK, Al Dhahani AA, Eatmadi H. Bilateral central retinal vein occlusion in a 40-year-old man with severe coronavirus disease 2019 (COVID-19) pneumonia Am J Case Rep. 2020;21:e927691

Acharya S, Diamond M, Anwar S, Glaser A, Tyagi P. Unique case of central retinal artery occlusion secondary to COVID-19 disease IDCases. 2020;21:e00867

Insausti-García A, Reche-Sainz JA, Ruiz-Arranz C, Vázquez ÁL, Ferro-Osuna M. Papillophlebitis in a COVID-19 patient: Inflammation and hypercoagulable state Eur J Ophthalmol. 2020 1120672120947591 doi: 10.1177/1120672120947591

Casagrande M, Fitzek A, Püschel K, Aleshcheva G, Schultheiss HP, Berneking L, et al Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients Ocul Immunol Inflamm. 2020;28:721–5

Sawalha K, Adeodokun S, Kamoga GR. COVID-19-induced acute bilateral optic neuritis? J Investig Med High Impact Case Rep. 2020;8 2324709620976018 doi: 10.1177/2324709620976018

Zhou S, Jones-Lopez EC, Soneji DJ, Azevedo CJ, Patel VR. Myelin oligodendrocyte glycoprotein antibody–associated optic neuritis and myelitis in COVID-19 J Neuroophthalmol. 2020 10.1097/WNO.0000000000001049 doi: 10.1097/WNO.0000000000001049

Tisdale AK, Chwalisz BK. Neuro-ophthalmic manifestations of coronavirus disease 19 Curr Opin Ophthalmol. 2020;31:489–94

Méndez-Guerrero A, Laespada-García MI, Gómez-Grande A, Ruiz-Ortiz M, Blanco-Palmero VA, Azcarate-Diaz FJ, et al Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection Neurology. 2020;95:e2109–18

Ortiz-Seller A, Martínez Costa L, Hernández-Pons A, Valls Pascual E, Solves Alemany A, Albert-Fort M. Ophthalmic and neuro-ophthalmic manifestations of coronavirus disease 2019 (COVID-19) Ocul Immunol Inflamm. 2020;28:1285–9

Politi LS, Salsano E, Grimaldi M. Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia JAMA Neurol. 2020;77:1028–9

Dinkin M, Gao V, Kahan J, Bobker S, Simonetto M, Wechsler P, et al COVID-19 presenting with ophthalmoparesis from cranial nerve palsy Neurology. 2020;95:221–3

Assini A, Benedetti L, Di Maio S, Schirinzi E, Del Sette M. New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: Two Italian cases Neurol Sci. 2020;41:1657–8

Huber M, Rogozinski S, Puppe W, Framme C, Höglinger G, Hufendiek K, et al Postinfectious onset of myasthenia gravis in a COVID-19 patient? Front Neurol. 2020;11:576153 doi: 10.3389/fneur.2020.576153

Cyr DG, Vicidomini CM, Siu NY, Elmann SE. Severe bilateral vision loss in 2 patients with coronavirus disease 2019 J Neuroophthalmol. 2020;40:403–5

Yang Y, Qidwai U, Burton BJ, Canepa C. Bilateral, vertical supranuclear gaze palsy following unilateral midbrain infarct BMJ Case Reports. 2020;13:e238422

Chen L, Liu M, Zhang Z, Qiao K, Huang T, Chen M, et al Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease Br J Ophthalmol. 2020;104:748–51 https://elibrary.ru/item.asp?id=48013267 , Шохаббос Саломов .

https://scholar.google.com/citations?view_op=view_citation&hl=ru&user=u7ktDD4AAAAJ&citation_for_view=u7ktDD4AAAAJ:2osOgNQ5qMEC

Salomov Shoxabbos Nozimjon og’li , http://conf.iscience.uz/index.php/yumti/article/download/72/66 , INTRAEPITHELIAL IN VARIOUS PARTS OF THE SMALL INTESTINE QUANTITATIVE INDICATORS OF LYMPHOCYTES .

Salomov Shoxabbos Nozimjon o’g’li, Abdusalomov Asadbek Xasanboy o’g’li , http://www.innovatus.es/index.php/ejine/article/view/29 , Quantitative Indicators of Villi Cells in the Intraepithelial Part of the Small Intestine